PZ Cormay S.A. (WSE:CRM)
Poland flag Poland · Delayed Price · Currency is PLN
0.5440
-0.0060 (-1.09%)
May 12, 2025, 4:02 PM CET
-12.26%
Market Cap 46.48M
Revenue (ttm) 91.62M
Net Income (ttm) -5.27M
Shares Out 84.21M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,836
Average Volume 68,080
Open 0.5440
Previous Close 0.5500
Day's Range 0.5440 - 0.5560
52-Week Range 0.3550 - 0.6300
Beta 1.02
RSI 52.72
Earnings Date May 16, 2025

About PZ Cormay

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names. The company also exports its products to approximately 150 countries, including Germany, Austria, France, Greece, Turkey, Ind... [Read more]

Sector Technology
Founded 1985
Employees 225
Stock Exchange Warsaw Stock Exchange
Ticker Symbol CRM
Full Company Profile

Financial Performance

In 2024, PZ Cormay's revenue was 91.62 million, an increase of 11.43% compared to the previous year's 82.23 million. Losses were -5.27 million, 17.1% more than in 2023.

Financial Statements

News

There is no news available yet.